drugset / Trial / NCT00993746

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula

NCT00993746 ↗

Phase 4 Unknown 90 enrolled Mahidol University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Will the technique of adding lidocaine to bupivacaine fasten the onset of bupivacaine alone for infraclavicular brachial plexus block in end-stage renal disease (ESRD) patient?

Timeline

Start
2009-10
Primary completion
2010-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 20 ml —
Comparator Bupivacaine Other / unclassified 30 ml —
Comparator Lidocaine Other / unclassified 10 ml —

Indications

No indication recorded.